Evidence map›Paper›PMID 33217930›Full record

ArticleJournal of fungi (Basel, Switzerland)2020

Drug-Resistant

Tra My N Duong, Phuong Tuyen Nguyen, Thanh Van Le, Huong Lan P Nguyen, Bich Ngoc T Nguyen, Bich Phuong T Nguyen, Thu Anh Nguyen, Sharon C-A Chen, Vanessa R Barrs, Catriona L Halliday and 3 more

Open access · goldAbstract read
In one paragraph

Article in Journal of fungi (Basel, Switzerland), 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed, 1 pooled it
0.3field-weighted citation impact, top 27% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 1 synthesis or guideline pooled it, 30 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Contribution of the CYP51A Y119F Mutation to Azole Resistance inJournal of fungi (Basel, Switzerland) · 2025
    Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Antifungal drug resistance: an update.European journal of hospital pharmacy : science and practice · 2022
    Article
  12. Article
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 5 institutions in 5 countries.

Tra My N DuongMarie Bashir Institute for Infectious Diseases and Biosecurity, The University of Sydney, Sydney 2145, Australia.
Phuong Tuyen NguyenOxford University Clinical Research Unit, Ho Chi Minh City 70000, Vietnam.
Thanh Van LeOxford University Clinical Research Unit, Ho Chi Minh City 70000, Vietnam.
Huong Lan P NguyenHospital for Tropical Diseases, Ho Chi Minh 70000, Vietnam.
Bich Ngoc T NguyenNational Lung Hospital, Hanoi 10000, Vietnam.
Bich Phuong T NguyenWoolcock Institute of Medical Research, Hanoi 10000, Vietnam.ORCID 0000-0003-0755-6944
Thu Anh NguyenMarie Bashir Institute for Infectious Diseases and Biosecurity, The University of Sydney, Sydney 2145, Australia.ORCID 0000-0002-2089-2902
Sharon C-A ChenMarie Bashir Institute for Infectious Diseases and Biosecurity, The University of Sydney, Sydney 2145, Australia.
Vanessa R BarrsMarie Bashir Institute for Infectious Diseases and Biosecurity, The University of Sydney, Sydney 2145, Australia.ORCID 0000-0001-6761-8022
Catriona L HallidayMarie Bashir Institute for Infectious Diseases and Biosecurity, The University of Sydney, Sydney 2145, Australia.
Tania C SorrellMarie Bashir Institute for Infectious Diseases and Biosecurity, The University of Sydney, Sydney 2145, Australia.ORCID 0000-0001-9460-0960
Jeremy N DayOxford University Clinical Research Unit, Ho Chi Minh City 70000, Vietnam.
Justin BeardsleyMarie Bashir Institute for Infectious Diseases and Biosecurity, The University of Sydney, Sydney 2145, Australia.
The University of Sydney · AUHanoi Medical University · VNOxford University Clinical Research Unit · VNHospital for Tropical Diseases · VNUniversity of Oxford · GB

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The burden of aspergillosis, especially Chronic Pulmonary Aspergillosis, is increasingly recognized, and the increasing presence of azole-resistant environmental

Indexed as

Aspergillus flavusazole resistanceenvironmental

Identifiers

PMID33217930
PMCPMC7711995
OpenAlexW3104551497

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.